2010
DOI: 10.1016/j.jjcc.2010.01.008
|View full text |Cite
|
Sign up to set email alerts
|

N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency

Abstract: NT-proBNP is a novel biomarker for integrated cardio-renal burden, and extremely useful for early risk stratification in the situation of cardiac emergency.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
20
0

Year Published

2011
2011
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(21 citation statements)
references
References 34 publications
1
20
0
Order By: Relevance
“…First, high level of BNP is a powerful marker of LV systolic dysfunction and poor prognosis after MI [7][8][9][10]. In patients with acute MI, increases in plasma BNP concentration during the early phase reflect MI size, and thereby may predict later LV function [7][8][9][10]27]. Accordantly, NT-proBNP levels were found to be correlated with LVEF and peak CK-MB levels in our study.…”
Section: Discussionsupporting
confidence: 76%
See 3 more Smart Citations
“…First, high level of BNP is a powerful marker of LV systolic dysfunction and poor prognosis after MI [7][8][9][10]. In patients with acute MI, increases in plasma BNP concentration during the early phase reflect MI size, and thereby may predict later LV function [7][8][9][10]27]. Accordantly, NT-proBNP levels were found to be correlated with LVEF and peak CK-MB levels in our study.…”
Section: Discussionsupporting
confidence: 76%
“…This may be explained by two proposals. First, high level of BNP is a powerful marker of LV systolic dysfunction and poor prognosis after MI [7][8][9][10]. In patients with acute MI, increases in plasma BNP concentration during the early phase reflect MI size, and thereby may predict later LV function [7][8][9][10]27].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Hs-cTnT at baseline and during follow-up is a powerful predictor of cardiac events in patients with HF and in the general population [3,4]. Natriuretic peptide concentrations have been shown to parallel with the clinical severity of congestive HF and cardiac dysfunction [5]. B-type natriuretic peptide (BNP) may be viewed as a marker of ventricular load and hs-cTnT as marker of myocardial injury [6].…”
Section: Introductionmentioning
confidence: 99%